Total Payments
$5,341
2024 Payments
$287.96
Companies
29
Transactions
285
Medicare Patients
1,197
Medicare Billing
$72,269
Payment Breakdown by Category
Food & Beverage$5,330 (99.8%)
Education$11.02 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,330 | 283 | 99.8% |
| Education | $11.02 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $975.93 | 45 | $0 (2024) |
| GlaxoSmithKline, LLC. | $648.06 | 35 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $532.52 | 42 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $416.30 | 17 | $0 (2022) |
| Novo Nordisk Inc | $394.22 | 10 | $0 (2022) |
| Lilly USA, LLC | $380.75 | 23 | $0 (2023) |
| PFIZER INC. | $327.60 | 28 | $0 (2023) |
| ABBVIE INC. | $306.21 | 18 | $0 (2024) |
| Allergan, Inc. | $247.53 | 9 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $187.67 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $287.96 | 4 | Otsuka America Pharmaceutical, Inc. ($121.82) |
| 2023 | $412.58 | 21 | GlaxoSmithKline, LLC. ($155.57) |
| 2022 | $511.37 | 24 | Novo Nordisk Inc ($137.12) |
| 2021 | $1,154 | 59 | GlaxoSmithKline, LLC. ($201.22) |
| 2020 | $582.63 | 22 | AstraZeneca Pharmaceuticals LP ($368.17) |
| 2019 | $441.73 | 26 | PFIZER INC. ($72.06) |
| 2018 | $627.31 | 33 | Boehringer Ingelheim Pharmaceuticals, Inc. ($198.02) |
| 2017 | $1,323 | 96 | Janssen Pharmaceuticals, Inc ($316.44) |
All Payment Transactions
285 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/25/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Diabetes Care | ||||||
| 03/28/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $121.82 | General |
| Category: PSYCHIATRY | ||||||
| 03/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $121.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: PSYCHIATRY | ||||||
| 11/27/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: Diabetes Care | ||||||
| 11/14/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Diabetes | ||||||
| 11/07/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: RESPIRATORY | ||||||
| 10/18/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Diabetes | ||||||
| 10/13/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: NEUROSCIENCE | ||||||
| 09/21/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: RESPIRATORY | ||||||
| 09/14/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: RESPIRATORY | ||||||
| 08/11/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: PSYCHIATRY | ||||||
| 07/06/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: RESPIRATORY | ||||||
| 06/23/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $11.15 | General |
| Category: VACCINES | ||||||
| 06/20/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Diabetes | ||||||
| 06/17/2023 | Lilly USA, LLC | EMGALITY (Drug), SYNJARDY, JARDIANCE | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Neuroscience | ||||||
| 05/25/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: RESPIRATORY | ||||||
| 04/18/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Spinal Cord Stimulator | ||||||
| 04/04/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: RESPIRATORY | ||||||
| 03/21/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: RESPIRATORY | ||||||
| 02/22/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $27.24 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/11/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/07/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 116 | 163 | $19,640 | $8,391 |
| 2022 | 4 | 134 | 232 | $21,090 | $11,531 |
| 2021 | 11 | 697 | 807 | $55,816 | $28,267 |
| 2020 | 6 | 250 | 444 | $48,300 | $24,080 |
Total Patients
1,197
Total Services
1,646
Medicare Billing
$72,269
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 64 | $10,680 | $3,842 | 36.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 22 | 32 | $5,700 | $2,529 | 44.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 11 | 11 | $1,950 | $1,383 | 70.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 28 | 38 | $510.00 | $319.20 | 62.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 18 | 18 | $800.00 | $318.60 | 39.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 68 | 149 | $17,880 | $9,531 | 53.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 14 | 14 | $2,100 | $1,713 | 81.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 40 | 55 | $550.00 | $163.08 | 29.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 12 | 14 | $560.00 | $123.99 | 22.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 64 | 140 | $16,800 | $9,317 | 55.5% |
| 0002A | Adm sarscov2 30mcg/0.3ml 2nd | Office | 2021 | 126 | 127 | $10,160 | $4,938 | 48.6% |
| 0003A | Fee covid-19 vac 1 booster | Office | 2021 | 105 | 105 | $8,400 | $4,082 | 48.6% |
| 0001A | Adm sarscov2 30mcg/0.3ml 1st | Office | 2021 | 124 | 124 | $9,920 | $3,350 | 33.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 20 | $3,000 | $1,915 | 63.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 11 | 11 | $1,650 | $1,458 | 88.4% |
| 0031A | Adm sarscov2 vac ad26 .5ml | Office | 2021 | 37 | 37 | $2,960 | $1,370 | 46.3% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 25 | 35 | $1,225 | $872.65 | 71.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 15 | 16 | $1,120 | $788.20 | 70.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 47 | 58 | $580.00 | $174.00 | 30.0% |
| 91300 | Sarscov2 vac 30mcg/0.3ml im | Office | 2021 | 126 | 134 | $1.34 | $1.34 | 100.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 63 | 136 | $20,400 | $11,080 | 54.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 84 | 185 | $22,200 | $9,828 | 44.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 19 | 19 | $2,850 | $2,161 | 75.8% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 16 | 17 | $1,530 | $603.63 | 39.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 54 | 72 | $720.00 | $215.40 | 29.9% |
About Dr. Leonel Camejo, MD
Dr. Leonel Camejo, MD is a Family Medicine healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1326008947.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Leonel Camejo, MD has received a total of $5,341 in payments from pharmaceutical and medical device companies, with $287.96 received in 2024. These payments were reported across 285 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($5,330).
As a Medicare-enrolled provider, Camejo has provided services to 1,197 Medicare beneficiaries, totaling 1,646 services with total Medicare billing of $72,269. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Tampa, FL
- Active Since 03/27/2006
- Last Updated 07/16/2018
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1326008947
Products in Payments
- FARXIGA (Drug) $679.07
- TRELEGY ELLIPTA (Drug) $487.94
- XARELTO (Drug) $348.64
- TRULICITY (Drug) $252.73
- VRAYLAR (Drug) $235.93
- INVOKANA (Drug) $177.86
- REXULTI (Drug) $168.26
- CHANTIX (Drug) $161.37
- BREZTRI (Drug) $140.88
- NAMENDA XR (Drug) $139.42
- Rybelsus (Drug) $137.12
- RYBELSUS (Drug) $124.81
- UBRELVY (Drug) $120.52
- ENTRESTO (Drug) $84.84
- SYMBICORT (Drug) $83.10
- ELIQUIS (Drug) $79.48
- Prolia (Biological) $74.40
- SPIRIVA RESPIMAT (Drug) $72.05
- STIOLTO RESPIMAT (Drug) $60.34
- ADVAIR (Drug) $57.83
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Tampa
Emily Horn, Pa, PA
Family Medicine — Payments: $151,588
Family Medicine $151,588
Dr. Michael Nieder, M.d, M.D
Family Medicine — Payments: $102,257
Family Medicine $102,257
Mr. Lon Lynn, D.o, D.O
Family Medicine — Payments: $34,536
Family Medicine $34,536
Dr. Srinivas Boppana, D.o, D.O
Family Medicine — Payments: $34,312
Family Medicine $34,312
Dr. Robert Mirsky, Md, MD
Family Medicine — Payments: $30,580
Family Medicine $30,580
Dr. Maria Del Pilar Cekan, M.d, M.D
Family Medicine — Payments: $20,296
Family Medicine $20,296